S&P 500

6.115,17

0,01%

Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.

Cadastre-se

Início
Investir
Ações
EUA
NASDAQ
Deep Medicine Acquisition Corporation (DMAQ)
Deep Medicine Acquisition Corporation (DMAQ) Notícias

DMAQ

Deep Medicine Acquisition (DMAQ)

Deep Medicine Acquisition Corporation

De:

Notícias regulamentadas

Procure um Texto:

Ordenação:

Notícias não regulamentadas

Apresentando as notícias mais relevantes sobre:NASDAQ:DMAQ

1 2 Próxima >>

Data	Hora	Fonte	Título	Código	Companhia
15/08/2024	14:13	Edgar (US Regulatory)	Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB	NASDAQ:DMAQ	Deep Medicine Acquisition Corporation
14/08/2024	17:31	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:DMAQ	Deep Medicine Acquisition Corporation
18/07/2024	17:30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:DMAQ	Deep Medicine Acquisition Corporation
17/04/2024	18:00	Edgar (US Regulatory)	Form 8-K/A - Current report: [Amend]	NASDAQ:DMAQ	Deep Medicine Acquisition Corporation
10/04/2024	18:00	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:DMAQ	Deep Medicine Acquisition Corporation
31/01/2024	18:46	GlobeNewswire Inc.	TRUGOLF, INC. AND DEEP MEDICINE ACQUISITION CORP. CLOSE BUSINESS COMBINATION; TRUGOLF BECOMES PUBLICLY TRADED COMPANY	NASDAQ:DMAQ	Deep Medicine Acquisition Corporation
25/01/2024	19:16	Edgar (US Regulatory)	Form 425 - Prospectuses and communications, business combinations	NASDAQ:DMAQ	Deep Medicine Acquisition Corporation
12/01/2024	18:10	GlobeNewswire Inc.	TRUGOLF, INC. AND NASDAQ-LISTED SPAC DEEP MEDICINE ACQUISITION CORP. ANNOUNCE FORM S-4 REGISTRATION STATEMENT DECLARED EFFECTIVE BY THE U.S. SECURITIES AND EXCHANGE COMMISSION AND MAILING OF DEFINITIVE PROXY STATEMENT	NASDAQ:DMAQ	Deep Medicine Acquisition Corporation
28/12/2023	02:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:DMAQ	Deep Medicine Acquisition Corporation
22/12/2023	18:10	Edgar (US Regulatory)	Form PRER14A - Preliminary Proxy Soliciting materials	NASDAQ:DMAQ	Deep Medicine Acquisition Corporation
20/12/2023	18:06	Edgar (US Regulatory)	Form S-4/A - Registration of securities, business combinations: [Amend]	NASDAQ:DMAQ	Deep Medicine Acquisition Corporation
15/12/2023	18:55	Edgar (US Regulatory)	Form PRE 14A - Other preliminary proxy statements	NASDAQ:DMAQ	Deep Medicine Acquisition Corporation
21/11/2023	18:10	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:DMAQ	Deep Medicine Acquisition Corporation
02/08/2023	21:55	GlobeNewswire Inc.	Deep Medicine Acquisition Corp. Announces its Filing of Registration Statement on Form S-4 in Connection with Merger with TruGolf, Inc.	NASDAQ:DMAQ	Deep Medicine Acquisition Corporation
31/07/2023	18:27	Edgar (US Regulatory)	Form S-4 - Registration of securities, business combinations	NASDAQ:DMAQ	Deep Medicine Acquisition Corporation
22/06/2023	17:31	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	NASDAQ:DMAQ	Deep Medicine Acquisition Corporation
06/06/2023	18:24	Edgar (US Regulatory)	Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)	NASDAQ:DMAQ	Deep Medicine Acquisition Corporation
31/05/2023	07:02	Edgar (US Regulatory)	Annual Report (10-k)	NASDAQ:DMAQ	Deep Medicine Acquisition Corporation
03/04/2023	07:17	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:DMAQ	Deep Medicine Acquisition Corporation
31/03/2023	23:03	GlobeNewswire Inc.	Deep Medicine Acquisition Corp. and TruGolf, Inc. Announce the Execution of a Definitive Merger Agreement	NASDAQ:DMAQ	Deep Medicine Acquisition Corporation
16/02/2023	18:25	GlobeNewswire Inc.	Deep Medicine Acquisition Corp. Announces Listing Transfer to the Nasdaq Capital Market	NASDAQ:DMAQ	Deep Medicine Acquisition Corporation
14/02/2023	12:12	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:DMAQ	Deep Medicine Acquisition Corporation
10/02/2023	18:32	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:DMAQ	Deep Medicine Acquisition Corporation
05/12/2022	08:05	Edgar (US Regulatory)	Proxy Soliciting Materials (revised) (prer14a)	NASDAQ:DMAQ	Deep Medicine Acquisition Corporation
25/10/2022	17:11	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:DMAQ	Deep Medicine Acquisition Corporation
24/10/2022	18:35	GlobeNewswire Inc.	Deep Medicine Acquisition Corp. Announces Appointment of a New Director	NASDAQ:DMAQ	Deep Medicine Acquisition Corporation
20/10/2022	17:30	GlobeNewswire Inc.	Deep Medicine Acquisition Corp. Confirms Funding to Extend Period to Consummate Initial Business Combination	NASDAQ:DMAQ	Deep Medicine Acquisition Corporation
20/09/2022	09:02	Edgar (US Regulatory)	Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)	NASDAQ:DMAQ	Deep Medicine Acquisition Corporation
27/04/2022	17:39	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	NASDAQ:DMAQ	Deep Medicine Acquisition Corporation
27/04/2022	17:37	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:DMAQ	Deep Medicine Acquisition Corporation